Liver Disease

Biopharmaceuticals
Liver Disease
Trade Of The Day

Aligos Therapeutics (ALGS): A Leader in Targeting Liver Diseases

Aligos Therapeutics, Inc. (ALGS) is a biopharmaceutical company dedicated to developing targeted therapies for viral and liver diseases. Their focus lies in addressing unmet medical needs, particularly in hepatitis B and non-alcoholic steatohepatitis (NASH). The company uses its proprietary technology platforms to create precision treatments that aim to improve patient outcomes significantly. Aligos’ core products […]

Read More
HeathCare
Kidney Disease
Liver Disease
Market Movers

Travere Therapeutics, Inc. (TVTX): New Hope for Rare Kidney Disorders

Featured Content Travere Therapeutics, Inc. (TVTX) is a biopharmaceutical company focused on developing and delivering therapies for rare and underserved diseases. Travere’s mission centers on advancing treatments for patients with serious and often overlooked conditions, primarily in the areas of nephrology (kidney diseases) and hepatology (liver diseases). The company’s pipeline includes innovative therapies aimed at […]

Read More
© Copyright 2020 Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.